Cost Assessment of Cryogenic Preservation of Biocollections during the COVID Pandemic at CeReB 2020-2021
Asian Journal of Biotechnology and Bioresource Technology,
Aims: Coronavirus 2019 (COVID-19) is a new human disease caused by the Coronavirus SARS-COV-2. It was classified as a pandemic by the World Health Organization (WHO) on March 11, 2020. The Institute Pasteur of Côte d'Ivoire (IPCI), through its specialized units and its Center National of Reference (CNR) for respiratory viruses, has been entrusted with the mission of coordinating the diagnostic and conservation efforts of COVID-19 for the country.
The objective of this study is to evaluate the costs of cryogenic conservation of biocollections during the COVID pandemic at the Côte d'Ivoire Biological Resource Center (CeReB) from 2020-2021.
Methodology: Cost and sample data were collected using a questionnaire administered to the IPCI administration, the Supply Management Unit (UGA) and CeReB staff that ensured data quality.
Results: For our study period, of the 1,225,710 SARS COV 2 samples collected by National Surveillance 92.7% (1,137,210/1,225,710) were received in IPCI laboratories for diagnosis.
Variable costs are higher than fixed costs in both cryovial and chaff collection production. The total production cost of the straw collection is 3.5 times the total production cost of the cryovial collection
Conclusion: This study establishes a generic analysis of the capital and operating costs required to integrate nasopharyngeal specimen cryopreservation and can serve as a model for the implementation of cryopreservation programs.
How to Cite
Gallien S, Guilmet C, Hurtes A, Omichessan H, Messaoudi F, Abou chakra C, et al. Costs of hospitalizations and follow-up and rehabilitation care related to COVID-19 in France in 2020. Medicine Mal Infect Form. 2022 Jun;1(2):S51.
DOI : 10.1016/j.mmifmc.2022.03.110
MSHP-CMU. COVID-19: Côte d ́ivoire new cases recorded this december 30, 2021. Abidjan: Ministry of Health, Public Hygiene and Universal Health Coverage; 2021 Dec.
Dauvin M, Ducoudré B, Heyer É, Madec P, Plane M, Sampognaro R, et al. Assessment as of June 26, 2020 of the economic impact of the Covid-19 pandemic and the containment and deconfinement measures in France: Rev OFCE. 2020 Nov 1;166(2):111‑60.
Ke X, Hsiao C. Economic impact of the most drastic lockdown during COVID‐19 pandemic—The experience of Hubei, China. J Appl Econom. 2022 Jan; 37(1):187‑209.
The repercussions of the Covid-19 health crisis on the moroccan economy. Journal of control, accounting and auditing [Internet]. [cited 2022 Oct 5].
Orangi S, Ojal J, Brand SPC, Orlendo C, Kairu A, Aziza R, et al. Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya [Internet]. medRxiv; 2022 [cited 2022 Oct 5]. p. 2022.04.21.22274150.
Nonvignon J, Owusu R, Asare B, Adjagba A, Aun YW, Yeung KHT, et al. Estimating the cost of COVID-19 vaccine deployment and introduction in Ghana using the CVIC tool. Vaccinated. 2022 Mar 15; 40(12): 1879‑87.
DOI : 10.1016/j.vaccine.2022.01.036
Kolia KI, Guédé KB, Kouassi KS, Obro KA, Odegue KD, Sina-Kouaméle SM, et al. Team experience of nasopharyngeal samples reception, decontamination, and sorting during the COVID-19 pandemic (2020) at Institut Pasteur Côte d'Ivoire. J Biosaf Biosecurity. 2021 Dec;3(2): 120‑4.
Hu E, Childress W, Tiersch TR. 3-D printing provides a novel approach for standardization and reproducibility of freezing devices. Cryobiology. 1 June 2017;76:34‑40.
DOI : 10.1016/j.cryobiol.2017.03.010
Clément B, Yuille M, Zaltoukal K, Wichmann HE, Anton G, Parodi B, et al. Public Biobanks: Calculation and Recovery of Costs. Sci Transl Med [Internet]. 2014 Nov 5 [cited 2022 Oct 5];6(261).
Dulloo ME, Ebert AW, Dussert S, Gotor E, Astorga C, Vasquez N, et al. Cost efficiency of cryopreservation as a long-term conservation method for coffee genetic resources. Crop Sci. 2009; 49(6):2123‑38.
DOI : 10.2135/cropsci2008.12.0736
Gao F, Tao L, Ma X, Lewandowski D, Shu Z. A study of policies and guidelines for collecting, processing, and storing coronavirus disease 2019 patient biospecimens for biobanking and research. Biopreservation Biobanking. 2020 Dec 1;18(6):511-6.
Matharoo-Ball B, Diop M, Kozlakidis Z. Harmonizing the COVID-19 sample biobanks: Barriers and opportunities for standards, best practices and networks. Biosaf Health. 2022 Aug;4(4):280‑2.
DOI : 10.1016/j.bsheal.2022.06.003
Carl Boodman MD, Philippe Lagacé-Wiens MD DTM&H, Jared Bullard MD. SARS-CoV-2 screening tests. 23 Nov 2020; 192(ISSUE 47).
Available at: www.cmaj.ca/lookup/
WHO Director-General’s opening remarks at the media briefing– 14 September 2022 - World | Relief Web [Internet]. [cited 2022 Oct 5].
Zahra DMF. The repercussions of the Covid-19 pandemic on the world economy and the Algerian Economy. 2022;50:18.
guide-to-research-on-cancer_fr.pdf [Internet]. [cited 2022 Oct 5].
Xiong X, Li J, Huang B, Tam T, Hong Y, Chong KC, et al. Economic value of vaccines to address the COVID-19 pandemic in Hong Kong: A cost-effectiveness analysis. Vaccines. 2022 Mar 23;10(4):495.
Abstract View: 53 times
PDF Download: 27 times